Eva Rivero‐Buceta

595 citations
20 papers · 473 indexed · h-index 13
Topics
Nanoparticle-Based Drug Delivery (5 papers)Nanoplatforms for cancer theranostics (5 papers)HIV Research and Treatment (4 papers)

In The Last Decade

Eva Rivero‐Buceta

19 papers receiving 470 citations

Peers

Eva Rivero‐Buceta
Comparison fields: 5 of 70
  • Biomaterials 171
  • Biomedical Engineering 170
  • Molecular Biology 155
  • Materials Chemistry 114
  • Inorganic Chemistry 70
Replace Ping Gao with:
Ping Gao China
Alessandra Monaco United Kingdom
Karol Ciepluch Poland
Joachim Caron France
Yansheng Dong China
Yonghuang Luo China
Lianyan Wang China
Badri Parshad Germany
Eva Rivero‐Buceta relative to Ping Gao China Ping Gao's profile →
Citations per field
00.5×1.5×2.3×
Ping Gao · 1×
Citations per year

Countries citing papers authored by Eva Rivero‐Buceta

Since Specialization
Citations

This map shows the geographic impact of Eva Rivero‐Buceta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Rivero‐Buceta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Rivero‐Buceta more than expected).

Fields of papers citing papers by Eva Rivero‐Buceta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Rivero‐Buceta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Rivero‐Buceta. The network helps show where Eva Rivero‐Buceta may publish in the future.

Co-authorship network of co-authors of Eva Rivero‐Buceta

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Rivero‐Buceta. A scholar is included among the top collaborators of Eva Rivero‐Buceta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Rivero‐Buceta. Eva Rivero‐Buceta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 8
3 8
4 6
5 34
6 3
7 12
8 19
9 25
10 54
11 47
12 39
13 16
14 90
15 18
16 16
17 33
18 10
19 24
20 11

About Eva Rivero‐Buceta

Eva Rivero‐Buceta is a scholar working on Virology, Biomaterials and Spectroscopy, having authored 20 papers that have together received 473 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (5 papers) and HIV Research and Treatment (4 papers). The work is most often cited by research in Biomaterials (171 citations), Virology (31 citations) and Inorganic Chemistry (70 citations). Eva Rivero‐Buceta has collaborated with scholars based in Spain, Belgium and United States. Frequent co-authors include Pablo Botella, Victoria Moreno‐Manzano, Eduardo Fernández, C.D. Vera Donoso, Avelino Corma, Ana San‐Félix, Christopher C. Landry, Ernesto Quesada, Marı́a-José Camarasa and Elisa G. Doyagüez. Their work appears in journals such as Journal of Colloid and Interface Science, Journal of Controlled Release and Nanoscale.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026